Recent Findings from City of Hope National Medical Center Has Provided New Information about Lymphoma (Phase I Trial of Brentuximab Vedotin Plus Cyclosporine In Relapsed/refractory Hodgkin Lymphoma)

Media coverage

• Title	Recent Findings from City of Hope National Medical Center Has Provided New Information about Lymphoma (Phase I Trial of Brentuximab Vedotin Plus Cyclosporine In Relapsed/refractory Hodgkin Lymphoma)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	10/22/24
  Persons	Lu Chen